PMID: 7535757Apr 10, 1995Paper

Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP-470, and mitomycin C on the growth and liver metastasis of human colon cancer

International Journal of Cancer. Journal International Du Cancer
H KonnoS Baba

Abstract

Angiogenesis inhibitors have attracted considerable interest. The anti-tumor and anti-metastatic effects of TNP-470, an angiogenesis inhibitor, and mitomycin C (MMC), a representative anti-neoplastic agent, were investigated using a xenotransplanted human colon cancer, TK-4. Suturing of small pieces of TK-4 tumors to the cecal wall in nude mice (orthotopic transplantation) induced liver metastasis. Mice were randomly divided into 3 groups; a control group given saline solution, a group receiving TNP-470 and a group receiving MMC. TNP-470 was given s.c. on alternate days for 5 weeks from day 10 after cecal transplantation and MMC was administered intraperitoneally (i.p.) once a week from day 10 after cecal transplantation. MMC significantly inhibited cecal tumor growth. In the control group, liver metastases developed in 9 out of 10 mice, including 3 with more than 20 metastatic foci. Liver metastasis also developed in 8 out of 10 mice receiving MMC, 2 of which had many metastases. In contrast, liver metastasis developed in only 2 out of 8 mice in the TNP-470 group and neither of these animals had numerous metastases.

References

Apr 1, 1992·Japanese Journal of Cancer Research : Gann·M IigoE Araki
Feb 14, 1991·Biochemical and Biophysical Research Communications·M KusakaJ Folkman
Oct 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·X Y FuR M Hoffman
Jan 1, 1985·Advances in Cancer Research·J Folkman
Mar 1, 1972·Annals of Surgery·J Folkman
May 27, 1982·Nature·S Taylor, J Folkman

❮ Previous
Next ❯

Citations

May 29, 1997·International Journal of Cancer. Journal International Du Cancer·T KanaiS Baba
Jun 1, 1996·Cancer Metastasis Reviews·V UmanskyV Schirrmacher
Nov 27, 2010·Cancer Chemotherapy and Pharmacology·Niranjan AwasthiRoderich E Schwarz
Apr 2, 1999·International Journal of Oral and Maxillofacial Surgery·K MatsumotoT Tomioka
Dec 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·V Castronovo, D Belotti
Jan 1, 1997·Surgical Oncology·T J HughG J Poston
Mar 24, 1998·Annual Review of Medicine·B R Zetter
Dec 31, 2009·Annals of Surgical Oncology·Roderich E SchwarzMargaret A Schwarz
Nov 4, 2000·Expert Opinion on Investigational Drugs·E A Kruger, W D Figg
Sep 1, 2010·Expert Opinion on Drug Discovery·Robert M Hoffman
Aug 10, 2000·Neoplasia : an International Journal for Oncology Research·D RibattiF Dammacco
Jan 1, 2014·International Journal of Cancer. Journal International Du Cancer·Shinichiro MiyazakiHiroyuki Konno
Feb 1, 1997·The Journal of Urology·Y TanakaR Oyasu
May 9, 2003·Surgical Oncology Clinics of North America·Michael O Meyers, James C Watson
Oct 21, 1999·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·M CromheeckeH J Hoekstra
Sep 1, 1996·Japanese Journal of Cancer Research : Gann·T ShishidoK Hirata
Jun 23, 2009·Pathophysiology : the Official Journal of the International Society for Pathophysiology·Chikao YasudaHitoshi Shiozaki
Feb 1, 2005·World Journal of Gastroenterology : WJG·I-Shyan SheenKuo-Ming Chang
Jan 8, 2005·World Journal of Gastroenterology : WJG·Lin JiaWen-Ge Huang
Mar 31, 2016·The Oncologist·Jill K Alldredge, Krishnansu S Tewari
May 18, 2013·Asian Pacific Journal of Cancer Prevention : APJCP·Yong-Hua ZhanXian-Qing Zhang
Oct 16, 2002·World Journal of Gastroenterology : WJG·Ying-Fang Fan, Zong-Hai Huang
May 13, 1999·International Journal of Experimental Pathology·P Gervaz, C Fontolliet
Aug 6, 2000·British Journal of Haematology·M MinischettiA F Dammacco

❮ Previous
Next ❯

Related Concepts

Related Feeds

Angiogenesis Inhibitors to Treat Cancer

Cancer treatments including angiogenesis inhibitors prevent tumor cells from receiving nutrients and oxygen. Here is the latest research on angiogenesis inhibitors for the treatment of cancer.